Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edward Thomas Ryan, D.T.M.&H., M.D.

Concepts

This page shows the publications Edward Ryan has written about Cholera Vaccines.
Connection Strength

7.366
  1. Cholera: recent updates. Curr Opin Infect Dis. 2018 10; 31(5):455-461.
    View in: PubMed
    Score: 0.636
  2. Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers. PLoS Negl Trop Dis. 2018 04; 12(4):e0006376.
    View in: PubMed
    Score: 0.615
  3. A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice. PLoS Negl Trop Dis. 2015; 9(7):e0003881.
    View in: PubMed
    Score: 0.508
  4. Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide. PLoS Negl Trop Dis. 2014 Feb; 8(2):e2683.
    View in: PubMed
    Score: 0.461
  5. Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin Vaccine Immunol. 2013 Jun; 20(6):780-8.
    View in: PubMed
    Score: 0.433
  6. Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin Vaccine Immunol. 2012 May; 19(5):690-8.
    View in: PubMed
    Score: 0.404
  7. Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice. Vaccine. 2009 Aug 06; 27(36):4917-22.
    View in: PubMed
    Score: 0.335
  8. Live attenuated oral cholera vaccines. Expert Rev Vaccines. 2006 Aug; 5(4):483-94.
    View in: PubMed
    Score: 0.274
  9. Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies. Vaccine. 2002 Jun 21; 20(21-22):2720-6.
    View in: PubMed
    Score: 0.206
  10. Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine. Infect Immun. 2021 08 16; 89(9):e0021721.
    View in: PubMed
    Score: 0.194
  11. Cholera vaccines. J Travel Med. 2001 Mar-Apr; 8(2):82-91.
    View in: PubMed
    Score: 0.188
  12. Cholera vaccines. Clin Infect Dis. 2000 Aug; 31(2):561-5.
    View in: PubMed
    Score: 0.182
  13. Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains. Infect Immun. 2000 Feb; 68(2):977-81.
    View in: PubMed
    Score: 0.174
  14. Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh. PLoS Negl Trop Dis. 2019 08; 13(8):e0007634.
    View in: PubMed
    Score: 0.168
  15. Oral immunization with a probiotic cholera vaccine induces broad protective immunity against Vibrio cholerae colonization and disease in mice. PLoS Negl Trop Dis. 2019 05; 13(5):e0007417.
    View in: PubMed
    Score: 0.166
  16. Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults. PLoS Negl Trop Dis. 2019 01; 13(1):e0007057.
    View in: PubMed
    Score: 0.163
  17. Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine. MMWR Morb Mortal Wkly Rep. 2017 May 12; 66(18):482-485.
    View in: PubMed
    Score: 0.144
  18. Conjugate Vaccines from Bacterial Antigens by Squaric Acid Chemistry: A Closer Look. Chembiochem. 2017 04 18; 18(8):799-815.
    View in: PubMed
    Score: 0.143
  19. Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children. PLoS Negl Trop Dis. 2016 Nov; 10(11):e0005039.
    View in: PubMed
    Score: 0.139
  20. Immune Responses to an Oral Cholera Vaccine in Internally Displaced Persons in South Sudan. Sci Rep. 2016 10 24; 6:35742.
    View in: PubMed
    Score: 0.139
  21. Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults. PLoS Negl Trop Dis. 2016 06; 10(6):e0004753.
    View in: PubMed
    Score: 0.136
  22. Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection. J Infect Dis. 2015 Sep 01; 212(5):779-83.
    View in: PubMed
    Score: 0.124
  23. Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti. PLoS Negl Trop Dis. 2014 May; 8(5):e2828.
    View in: PubMed
    Score: 0.117
  24. Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera. Am J Trop Med Hyg. 2014 May; 90(5):873-81.
    View in: PubMed
    Score: 0.116
  25. Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh. Clin Vaccine Immunol. 2013 Oct; 20(10):1592-8.
    View in: PubMed
    Score: 0.111
  26. Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine. Clin Vaccine Immunol. 2013 Oct; 20(10):1541-8.
    View in: PubMed
    Score: 0.111
  27. Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera. Clin Vaccine Immunol. 2012 Aug; 19(8):1304-11.
    View in: PubMed
    Score: 0.103
  28. Immune responses to cholera in children. Expert Rev Anti Infect Ther. 2012 Apr; 10(4):435-44.
    View in: PubMed
    Score: 0.101
  29. Haiti in the context of the current global cholera pandemic. Emerg Infect Dis. 2011 Nov; 17(11):2175-6.
    View in: PubMed
    Score: 0.098
  30. Cholera in the 21st century. Curr Opin Infect Dis. 2011 Oct; 24(5):472-7.
    View in: PubMed
    Score: 0.098
  31. Simple, direct conjugation of bacterial O-SP-core antigens to proteins: development of cholera conjugate vaccines. Bioconjug Chem. 2011 Oct 19; 22(10):2179-85.
    View in: PubMed
    Score: 0.098
  32. Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera. Clin Vaccine Immunol. 2011 May; 18(5):844-50.
    View in: PubMed
    Score: 0.094
  33. The cholera pandemic, still with us after half a century: time to rethink. PLoS Negl Trop Dis. 2011 Jan 25; 5(1):e1003.
    View in: PubMed
    Score: 0.093
  34. Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice. Infect Immun. 2006 Oct; 74(10):5834-9.
    View in: PubMed
    Score: 0.069
  35. Postgenomic approaches to cholera vaccine development. Expert Rev Vaccines. 2006 Jun; 5(3):337-46.
    View in: PubMed
    Score: 0.068
  36. Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae. mSphere. 2019 08 21; 4(4).
    View in: PubMed
    Score: 0.042
  37. Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection. Clin Vaccine Immunol. 2013 Jan; 20(1):17-23.
    View in: PubMed
    Score: 0.026
  38. Cholera. Lancet. 2012 Jun 30; 379(9835):2466-2476.
    View in: PubMed
    Score: 0.026
  39. Vibrio cholerae O1 infection induces proinflammatory CD4+ T-cell responses in blood and intestinal mucosa of infected humans. Clin Vaccine Immunol. 2011 Aug; 18(8):1371-7.
    View in: PubMed
    Score: 0.024
  40. A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh. Pediatr Infect Dis J. 2008 Nov; 27(11):986-92.
    View in: PubMed
    Score: 0.020
  41. Reduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in Bangladesh. Infect Immun. 2005 Oct; 73(10):6577-83.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.